Degenerative and regenerative mechanisms governing spinal cord injury

Neurobiology of Disease

Volumn 15, Issue 3, 2004, Pages 415-436

  Profyris, Christos ^a   Cheema, Surindar S ^a   Zang, DaWei ^a   Azari, Michael F ^a   Boyle, Kristy ^a   Petratos, Steven ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Leukaemia inhibitory factor (LIF); Nogo; Oligodendrocyte apoptosis; Secondary demyelination; Spinal cord injury; Wallerian degeneration

Indexed keywords

APOPTOSIS; ASTROCYTE; BLEEDING; CELL DEATH; CENTRAL NERVOUS SYSTEM; GLIOSIS; HELPER CELL; HUMAN; IMMUNE SYSTEM; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MOLECULAR MECHANICS; MOTOR DYSFUNCTION; NERVE CONDUCTION; NERVE FIBER REGENERATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REGENERATION; REVIEW; SPINAL CORD ATROPHY; SPINAL CORD INJURY;

ANIMALS; APOPTOSIS; HUMANS; NERVE DEGENERATION; NERVE REGENERATION; OLIGODENDROGLIA; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

EID: 1842419475     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2003.11.015     Document Type: Review

References (196)

1. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev., Neurosci. 2:2001;734-744.
2. Amano M., Ito M., Kimura K., Fukata Y., Chihara K., Nakano T., Matsuura Y., Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271:1996;20246-20249.
3. Anthes D.L., Theriault E., Tator C.H. Characterization of axonal ultrastructural pathology following experimental spinal cord compression injury. Brain Res. 702:1995;1-16.
4. Arber S., Barbayannis F.A., Hanser H., Schneider C., Stanyon C.A., Bernard O., Caroni P. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. Nature. 393:1998;805-809.
5. Arnett H.A., Mason J., Marino M., Suzuki K., Matsushima G.K., Ting J.P. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4:2001;1116-1122.
6. Bannister L.H. Connective tissues. Williams P.L., Bannister L.H., Berry M.M., Collins P., Dyson M., Dussek J.E., Ferguson M.W.J. Gray's Anatomy. thirty-eight ed. 1999;75-90 Churchill Livingstone, Edinburgh.
7. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70:1992;31-46.
8. Barres B.A., Schmid R., Sendnter M., Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 118:1993;283-295.
9. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 9:1997;1422-1438.
10. Beattie M.S., Farooqui A.A., Bresnahan J.C. Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma. 17:2000;915-925.
11. Beattie M.S., Harrington A.W., Lee R., Kim J.Y., Boyce S.L., Longo F.M., Bresnahan J.C., Hempstead B.L., Yoon S.O. ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron. 36:2002;375-386.
12. Beattie M.S., Hermann G.E., Rogers R.C., Bresnahan J.C. Cell death in models of spinal cord injury. Prog. Brain Res. 137:2002;37-47.
13. Bethea J.R., Castro M., Keane R.W., Lee T.T., Dietrich W.D., Yezierski R.P. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J. Neurosci. 18:1998;3251-3260.
14. Bignami A., Dahl D. General Pathology. Medical Intelligence Unit: Glial Cells In The Central Nervous System And Their Reaction To Injury. first ed. 1994;77-92 R.G. Landes Company, Austin.
15. Blight A.R. Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neuroscience. 10:1983;521-543.
16. Blight A. Mechanical factors in experimental spinal cord injury. J. Am. Parapleg. Soc. 11:1988;26-34.
17. Blight A.R., Decrescito V. Morphometric analysis of experimental spinal cord injury in the cat: the relation of injury intensity to survival of myelinated axons. Neuroscience. 19:1986;321-341.
18. Bowman T., Garcia R., Turkson J., Jove R. STATs in oncogenesis. Oncogene. 19:2000;2474-2488.
19. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature. 416:2002;636-640.
20. Bresnahan J.C., Beattie M.S., Todd F.D. III, Noyes D.H. A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp. Neurol. 95:1987;548-570.
21. Buffo A., Zagrebelsky M., Huber A.B., Skerra A., Schwab M.E., Strata P., Rossi F. Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured Purkinje cell axons. J. Neurosci. 20:2000;2275-2286.
22. Bunge R.P., Puckett W.R., Becerra J.L., Marcillo A., Quencer R.M. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 59:1993;75-89.
23. Burg M.A., Tillet E., Timpl R., Stallcup W.B. Binding of the NG2 proteoglycan to type VI collagen and other extracellular matrix molecules. J. Biol. Chem. 271:1996;26110-26116.
24. Butzkueven H., Zhang J.G., Soilu-Hanninen M., Hochrein H., Chionh F., Shipham K.A., Emery B., Turnley A.M., Petratos S., Ernst M., Bartlett P.F., Kilpatrick T.J. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 8:2002;613-619.
25. Carlson S.L., Parrish M.E., Springer J.E., Doty K., Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151:1998;77-88.
26. Casaccia-Bonnefil P. Cell death in the oligodendrocyte lineage: a molecular perspective of life/death decisions in development and disease. Glia. 29:2000;124-135.
27. Casaccia-Bonnefil P., Carter B.D., Dobrowsky R.T., Chao M.V. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 383:1996;716-719.
28. Casha S., Yu W.R., Fehlings M.G. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience. 103:2001;203-218.
29. Cassatella M.A. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today. 16:1995;21-26.
30. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science. 296:2002;1634-1635.
31. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:2000;434-439.
32. Choi D.W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 6:1996;667-672.
33. Cotran R.S., Kumar V., Collins T. Cellular pathology I: cell injury and cell death. Venkatachalam M. Robbins Pathologic Basis of Disease. sixth ed. 1999;5-18 W.B. Saunders Company, Philadelphia.
34. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Beattie M.S. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3:1997;73-76.
35. David S. Recruiting the immune response to promote long distance axon regeneration after spinal cord injury. Prog. Brain Res. 137:2002;407-414.
36. Dechant G., Barde Y.A. Signalling through the neurotrophin receptor p75NTR. Curr. Opin. Neurobiol. 7:1997;413-418.
37. de la Torre J.C. Spinal cord injury. Review of basic and applied research. Spine. 6:1981;315-335.
38. Dergham P., Ellezam B., Essagian C., Avedissian H., Lubell W.D., McKerracher L. Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22:2002;6570-6577.
39. Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy. Pharmacol. Ther. 81:1999;163-221.
40. D'Souza S.D., Alinauskas K.A., Antel J.P. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J. Neurosci. Res. 43:1996;289-298.
41. D'Souza S.D., Bonetti B., Balasingam V., Cashman N.R., Barker P.A., Troutt A.B., Raine C.S., Antel J.P. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:1996;2361-2370.
42. Dusart I., Schwab M.E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 6:1994;712-724.
43. Ehrhard P.B., Erb P., Graumann U., Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10984-10988.
44. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 49:1999;377-391.
45. Fitch M.T., Doller C., Combs C.K., Landreth G.E., Silver J. Cellular and molecular mechanisms of glial scarring and progressive cavitation: in vivo and in vitro analysis of inflammation-induced secondary injury after CNS trauma. J. Neurosci. 19:1999;8182-8198.
46. Flores A.I., Mallon B.S., Matsui T., Ogawa W., Rosenzweig A., Okamoto T., Macklin W.B. Akt-mediated survival of oligodendrocytes induced by neuregulins. J. Neurosci. 20:2000;7622-7630.
47. Fournier A.E., GrandPre T., Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 409:2001;341-346.
48. Frisen J., Haegerstrand A., Fried K., Piehl F., Cullheim S., Risling M. Adhesive/repulsive properties in the injured spinal cord: relation to myelin phagocytosis by invading macrophages. Exp. Neurol. 129:1994;183-193.
49. George R., Griffin J.W. The proximo-distal spread of axonal degeneration in the dorsal columns of the rat. J. Neurocytol. 23:1994;657-667.
50. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444.
51. Grimpe B., Silver J. The extracellular matrix in axon regeneration. Prog. Brain Res. 137:2002;333-349.
52. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma. 9:1992;123-126. (discussion 126-128).
53. Gruner J.A., Yee A., Blight A.R. Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression. Brain Res. 729:1996;90-101.
54. Gu C., Casaccia-Bonnefil P., Srinivasan A., Chao M.V. Oligodendrocyte apoptosis mediated by caspase activation. J. Neurosci. 19:1999;3043-3049.
55. Guha A., Tator C.H. Acute cardiovascular effects of experimental spinal cord injury. J. Trauma. 28:1988;481-490.
56. Gupta S. A decision between life and death during TNF-alpha-induced signaling. J. Clin. Immunol. 22:2002;185-194.
57. Guth L., Zhang Z., Steward O. The unique histopathological responses of the injured spinal cord. Implications for neuroprotective therapy. Ann. N.Y. Acad. Sci. 890:1999;366-384.
58. Hall E.D. The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76:1992;13-22.
59. Hamada Y., Ikata T., Katoh S., Katoh K., Niwa M., Tsutsumishita Y., Fukuzawa K. Effects of exogenous transforming growth factor-beta 1 on spinal cord injury in rats. Neurosci. Lett. 203:1996;97-100.
60. Harrington A.W., Kim J.Y., Yoon S.O. Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis. J. Neurosci. 22:2002;156-166.
61. Harris C.A., Johnson E.M. Jr. BH3-only Bcl-2 family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neurons. J. Biol. Chem. 276:2001;37754-37760.
62. Hauben E., Schwartz M. Therapeutic vaccination for spinal cord injury: helping the body to cure itself. Trends Pharmacol. Sci. 24:2003;7-12.
63. Hauben E., Butovsky O., Nevo U., Yoles E., Moalem G., Agranov E., Mor F., Leibowitz-Amit R., Pevsner E., Akselrod S., Neeman M., Cohen I.R., Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J. Neurosci. 20:2000;6421-6430.
64. Hausmann O.N. Post-traumatic inflammation following spinal cord injury. Spinal Cord. 41:2003;369-378.
65. Heese K., Hock C., Otten U. Inflammatory signals induce neurotrophin expression in human microglial cells. J. Neurochem. 70:1998;699-707.
66. Heinrich P.C., Behrmann I., Muller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:1998;297-314.
67. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
68. Herx L.M., Rivest S., Yong V.W. Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J. Immunol. 165:2000;2232-2239.
69. Huber A.B., Schwab M.E. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol. Chem. 381:2000;407-419.
70. Janmey P.A., Stossel T.P. Modulation of gelsolin function by phosphatidylinositol 4,5-bisphosphate. Nature. 325:1987;362-364.
71. Josephson A., Trifunovski A., Widmer H.R., Widenfalk J., Olson L., Spenger C. Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J. Comp. Neurol. 453:2002;292-304.
72. Joshi M., Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J. Neurotrauma. 19:2002;175-190.
73. Joshi M., Fehlings M.G. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J. Neurotrauma. 19:2002;191-203.
74. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J. Exp. Med. 189:1999;865-870.
75. Kim G.M., Xu J., Song S.K., Yan P., Ku G., Xu X.M., Hsu C.Y. Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury. J. Neurosci. 21:2001;6617-6625.
76. Kim J.E., Li S., Grandpré T., Qiu D., Strittmatter S.M. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron. 38:2003;187-199.
77. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M., Yamamori B., Feng J., Nakano T., Okawa K., Iwamatsu A., Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 273:1996;245-248.
78. Kimura M.T., Irie S., Shoji-Hoshino S., Mukai J., Nadano D., Oshimura M., Sato T.A. 14-3-3 is involved in p75 neurotrophin receptor-mediated signal transduction. J. Biol. Chem. 276:2001;17291-17300.
79. Kipnis J., Yoles E., Schori H., Hauben E., Shaked I., Schwartz M. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J. Neurosci. 21:2001;4564-4571.
80. Kitamura M. Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as TGF-beta 1. J. Immunol. 159:1997;1404-1411.
81. Klusman I., Schwab M.E. Effects of pro-inflammatory cytokines in experimental spinal cord injury. Brain Res. 762:1997;173-184.
82. Koshinaga M., Whittemore S.R. The temporal and spatial activation of microglia in fiber tracts undergoing anterograde and retrograde degeneration following spinal cord lesion. J. Neurotrauma. 12:1995;209-222.
83. Kottis V., Thibault P., Mikol D., Xiao Z.C., Zhang R., Dergham P., Braun P.E. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 82:2002;1566-1569.
84. Koyanagi I., Tator C.H., Lea P.J. Three-dimensional analysis of the vascular system in the rat spinal cord with scanning electron microscopy of vascular corrosion casts. Part 2: acute spinal cord injury. Neurosurgery. 33:1993;285-291. (discussion 292).
85. Lee Y.B., Yune T.Y., Baik S.Y., Shin Y.H., Du S., Rhim H., Lee E.B., Kim Y.C., Shin M.L., Markelonis G.J., Oh T.H. Role of tumor necrosis factor-alpha in neuronal and glial apoptosis after spinal cord injury. Exp. Neurol. 166:2000;190-195.
86. Lee Y.L., Shih K., Bao P., Ghirnikar R.S., Eng L.F. Cytokine chemokine expression in contused rat spinal cord. Neurochem. Int. 36:2000;417-425.
87. Lee R., Kermani P., Teng K.K., Hempstead B.L. Regulation of cell survival by secreted proneurotrophins. Science. 294:2001;1945-1948.
88. Leskovar A., Moriarty L.J., Turek J.J., Schoenlein I.A., Borgens R.B. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J. Exp. Biol. 203:2000;1783-1795.
89. Leung T., Chen X.Q., Manser E., Lim L. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol. 16:1996;5313-5327.
90. Li G.L., Farooque M., Holtz A., Olsson Y. Apoptosis of oligodendrocytes occurs for long distances away from the primary injury after compression trauma to rat spinal cord. Acta Neuropathol. (Berl). 98:1999;473-480.
91. Li Y., Field P.M., Raisman G. Death of oligodendrocytes and microglial phagocytosis of myelin precede immigration of Schwann cells into the spinal cord. J. Neurocytol. 28:1999;417-427.
92. Liu B.P., Fournier A., GrandPre T., Strittmatter S.M. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 297:2002;1190-1193.
93. Maekawa M., Ishizaki T., Boku S., Watanabe N., Fujita A., Iwamatsu A., Obinata T., Ohashi K., Mizuno K., Narumiya S. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science. 285:1999;895-898.
94. Manser E., Chong C., Zhao Z.S., Leung T., Michael G., Hall C., Lim L. Molecular cloning of a new member of the p21-Cdc42/Rac-activated kinase (PAK) family. J. Biol. Chem. 270:1995;25070-25078.
95. Mason J.L., Suzuki K., Chaplin D.D., Matsushima G.K. Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21:2001;7046-7052.
96. Mattson M.P., Rychlik B., Chu C., Christakos S. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron. 6:1991;41-51.
97. Matute C., Alberdi E., Domercq M., Perez-Cerda F., Perez-Samartin A., Sanchez-Gomez M.V. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24:2001;224-230.
98. Maxwell W.L. Histopathological changes at central nodes of Ranvier after stretch-injury. Microsc. Res. Tech. 34:1996;522-535.
99. Mayer M., Bhakoo K., Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development. 120:1994;143-153.
100. Maynard F.M. Jr., Bracken M.B., Creasey G., Ditunno J.F. Jr., Donovan W.H., Ducker T.B., Garber S.L., Marino R.J., Stover S.L., Tator C.H., Waters R.L., Wilberger J.E., Young W. International standards for neurological and functional classification of spinal cord injury. American spinal injury association. Spinal Cord. 35:1997;266-274.
101. McDonald P.P., Bald A., Cassatella M.A. Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils. Blood. 89:1997;3421-3433.
102. McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W., Goldberg M.P. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4:1998;291-297.
103. McKerracher L., Winton M.J. Nogo on the go. Neuron. 36:2002;345-348.
104. McKerracher L., David S., Jackson D.L., Kottis V., Dunn R.J., Braun P.E. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron. 13:1994;805-811.
105. McTigue D.M., Tani M., Krivacic K., Chernosky A., Kelner G.S., Maciejewski D., Maki R., Ransohoff R.M., Stokes B.T. Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury. J. Neurosci. Res. 53:1998;368-376.
106. McTigue D.M., Wei P., Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci. 21:2001;3392-3400.
107. Meyer G., Feldman E.L. Signaling mechanisms that regulate actin-based motility processes in the nervous system. J. Neurochem. 83:2002;490-503.
108. Middleton G., Hamanoue M., Enokido Y., Wyatt S., Pennica D., Jaffray E., Hay R.T., Davies A.M. Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J. Cell Biol. 148:2000;325-332.
109. Miller R.H. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev. Biol. 216:1999;359-368.
110. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5:1999;49-55.
111. Moalem G., Monsonego A., Shani Y., Cohen I.R., Schwartz M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 13:1999;1207-1217.
112. Moalem G., Gdalyahu A., Shani Y., Otten U., Lazarovici P., Cohen I.R., Schwartz M. Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J. Autoimmun. 15:2000;331-345.
113. Morgenstern D.A., Asher R.A., Fawcett J.W. Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137:2002;313-332.
114. Morita Y., Naka T., Kawazoe Y., Fujimoto M., Narazaki M., Nakagawa R., Fukuyama H., Nagata S., Kishimoto T. Signals transducers and activators of transcription (STAT)-induced STAT inhibitor-1 (SSI-1)/suppressor of cytokine signaling-1 (SOCS-1) suppresses tumor necrosis factor alpha-induced cell death in fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 97:2000;5405-5410.
115. Mukai J., Hachiya T., Shoji-Hoshino S., Kimura M.T., Nadano D., Suvanto P., Hanaoka T., Li Y., Irie S., Greene L.A., Sato T.A. NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR. J. Biol. Chem. 275:2000;17566-17570.
116. Mukhopadhyay G., Doherty P., Walsh F.S., Crocker P.R., Filbin M.T. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron. 13:1994;757-767.
117. Nakahara S., Yone K., Sakou T., Wada S., Nagamine T., Niiyama T., Ichijo H. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis. J. Neuropathol. Exp. Neurol. 58:1999;442-450.
118. Ng C.E., Tang B.L. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration. J. Neurosci. Res. 67:2002;559-565.
119. Ng W.P., Cartel N., Roder J., Roach A., Lozano A. Human central nervous system myelin inhibits neurite outgrowth. Brain Res. 720:1996;17-24.
120. Nguyen M.D., Julien J.P., Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat. Rev., Neurosci. 3:2002;216-227.
121. Niederost B., Oertle T., Fritsche J., McKinney R.A., Bandtlow C.E. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 22:2002;10368-10376.
122. Noble L.J., Wrathall J.R. Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp. Neurol. 88:1985;135-149.
123. Noble L.J., Donovan F., Igarashi T., Goussev S., Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J. Neurosci. 22:2002;7526-7535.
124. Nottingham S., Knapp P., Springer J. FK506 treatment inhibits caspase-3 activation and promotes oligodendroglial survival following traumatic spinal cord injury. Exp. Neurol. 177:2002;242-251.
125. Olivares-Villagomez D., Wang Y., Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 188:1998;1883-1894.
126. Ozawa H., Keane R.W., Marcillo A.E., Diaz P.H., Dietrich W.D. Therapeutic strategies targeting caspase inhibition following spinal cord injury in rats. Exp. Neurol. 177:2002;306-313.
127. Pan W., Kastin A.J. Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion. Exp. Neurol. 170:2001;357-363.
128. Pan W., Kastin A.J., Bell R.L., Olson R.D. Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury. J. Neurosci. 19:1999;3649-3655.
129. Pan J.Z., Ni L., Sodhi A., Aguanno A., Young W., Hart R.P. Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J. Neurosci. Res. 68:2002;315-322.
130. Panter S.S., Yum S.W., Faden A.I. Alteration in extracellular amino acids after traumatic spinal cord injury. Ann. Neurol. 27:1990;96-99.
131. Pignot V., Hein A.E., Barske C., Wiessner C., Walmsley A.R., Kaupmann K., Mayeur H., Sommer B., Mir A.K., Frentzel S. Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor. J. Neurochem. 85:2003;717-728.
132. Popovich P.G., Hickey W.F. Bone marrow chimeric rats reveal the unique distribution of resident and recruited macrophages in the contused rat spinal cord. J. Neuropathol. Exp. Neurol. 60:2001;676-685.
133. Popovich P.G., Jones T.B. Manipulating neuroinflammatory reactions in the injured spinal cord: back to basics. Trends Pharmacol. Sci. 24:2003;13-17.
134. Popovich P.G., Streit W.J., Stokes B.T. Differential expression of MHC class II antigen in the contused rat spinal cord. J. Neurotrauma. 10:1993;37-46.
135. Popovich P.G., Stokes B.T., Whitacre C.C. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 45:1996;349-363.
136. Popovich P.G., Wei P., Stokes B.T. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J. Comp. Neurol. 377:1997;443-464.
137. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature. 403:2000;383-384.
138. Puchalski R.B., Louis J.C., Brose N., Traynelis S.F., Egebjerg J., Kukekov V., Wenthold R.J., Rogers S.W., Lin F., Moran T.et al. Selective RNA editing and subunit assembly of native glutamate receptors. Neuron. 13:1994;131-147.
139. Quencer R.M. Advances in imaging of spinal cord injury: implications for treatment and patient evaluation. Prog. Brain Res. 137:2002;3-8.
140. Rabchevsky A.G., Smith G.M. Therapeutic interventions following mammalian spinal cord injury. Arch. Neurol. 58:2001;721-726.
141. Raff M.C., Barres B.A., Burne J.F., Coles H.S., Ishizaki Y., Jacobson M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science. 262:1993;695-700.
142. Rohatgi R., Ho H.Y., Kirschner M.W. Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4,5-bisphosphate. J. Cell Biol. 150:2000;1299-1310.
143. Ropper A.H. Traumatic injuries of the head and spine. Braunwald E., Fauci A.S., Kasper D.L., Hauser S.L., Longo D.L., Jameson J.L. Harrison's Principles of Internal Medicine. fifteenth ed. 2001;2441-2442 McGraw-Hill, New York.
144. Roux P.P., Barker P.A. Neurotrophin signaling through the p75 neurotrophin receptor. Prog. Neurobiol. 67:2002;203-233.
145. Sanders L.C., Matsumura F., Bokoch G.M., de Lanerolle P. Inhibition of myosin light chain kinase by p21-activated kinase. Science. 283:1999;2083-2085.
146. Sanes J.R., Jessell T.M. The guidance of axons to their targets. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of neural science. fourth ed. 2000;1063-1086 McGraw-Hill, New York.
147. Sanes J.R., Jessell T.M. The formation and regeneration of synapses. Kandel E.R., Schwartz J.H., Jessell T.M. Principles of neural science. fourth ed. 2000;1087-1114 McGraw-Hill, New York.
148. Satake K., Matsuyama Y., Kamiya M., Kawakami H., Iwata H., Adachi K., Kiuchi K. Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury. Brain Res., Mol. Brain Res. 85:2000;114-122.
149. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 407:2000;784-788.
150. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225.
151. Schmitt A.B., Buss A., Breuer S., Brook G.A., Pech K., Martin D., Schoenen J., Noth J., Love S., Schroder J.M., Kreutzberg G.W., Nacimiento W. Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response. Acta Neuropathol. (Berl). 100:2000;528-536.
152. Schnell L., Fearn S., Klassen H., Schwab M.E., Perry V.H. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 11:1999;3648-3658.
153. Schwab M.E. Increasing plasticity and functional recovery of the lesioned spinal cord. Prog. Brain Res. 137:2002;351-359.
154. Schwab J.M., Brechtel K., Nguyen T.D., Schluesener H.J. Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J. Neuroimmunol. 111:2000;122-130.
155. Schwab J.M., Frei E., Klusman I., Schnell L., Schwab M.E., Schluesener H.J. AIF-1 expression defines a proliferating and alert microglial/macrophage phenotype following spinal cord injury in rats. J. Neuroimmunol. 119:2001;214-222.
156. Schwartz G., Fehlings M.G. Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole. Prog. Brain Res. 137:2002;177-190.
157. Schwartz M., Hauben E. T cell-based therapeutic vaccination for spinal cord injury. Prog. Brain Res. 137:2002;401-406.
158. Segal R.A., Greenberg M.E. Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19:1996;463-489.
159. Semple-Rowland S.L., Mahatme A., Popovich P.G., Green D.A., Hassler G. Jr., Stokes B.T., Streit W.J. Analysis of TGF-beta 1 gene expression in contused rat spinal cord using quantitative RT-PCR. J. Neurotrauma. 12:1995;1003-1014.
160. Shuman S.L., Bresnahan J.C., Beattie M.S. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J. Neurosci. Res. 50:1997;798-808.
161. Simonen M., Pedersen V., Weinmann O., Schnell L., Buss A., Ledermann B., Christ F., Sansig G., van der Putten H., Schwab M.E. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron. 38:2003;201-211.
162. Steinhauser C., Gallo V. News on glutamate receptors in glial cells. Trends Neurosci. 19:1996;339-345.
163. Takahashi M., Arai Y., Kurosawa H., Sueyoshi N., Shirai S. Ependymal cell reactions in spinal cord segments after compression injury in adult rat. J. Neuropathol. Exp. Neurol. 62:2003;185-194.
164. Takano R., Hisahara S., Namikawa K., Kiyama H., Okano H., Miura M. Nerve growth factor protects oligodendrocytes from tumor necrosis factor-alpha- induced injury through Akt-mediated signaling mechanisms. J. Biol. Chem. 275:2000;16360-16365.
165. Tanaka S., Koike T. Selective inflammatory stimulations enhance release of microglial response factor (MRF)-1 from cultured microglia. Glia. 40:2002;360-371.
166. Taoka Y., Okajima K., Uchiba M., Murakami K., Kushimoto S., Johno M., Naruo M., Okabe H., Takatsuki K. Role of neutrophils in spinal cord injury in the rat. Neuroscience. 79:1997;1177-1182.
167. Tator C.H. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol. 5:1995;407-413.
168. Tator C.H., Fehlings M.G. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75:1991;15-26.
169. Thallmair M., Metz G.A., Z'Graggen W.J., Raineteau O., Kartje G.L., Schwab M.E. Neurite growth inhibitors restrict plasticity and functional recovery following corticospinal tract lesions. Nat. Neurosci. 1:1998;124-131.
170. Tolias K.F., Cantley L.C., Carpenter C.L. Rho family GTPases bind to phosphoinositide kinases. J. Biol. Chem. 270:1995;17656-17659.
171. Tolias K.F., Rameh L.E., Ishihara H., Shibasaki Y., Chen J., Prestwich G.D., Cantley L.C., Carpenter C.L. Type I phosphatidylinositol-4-phosphate 5-kinases synthesize the novel lipids phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 5-phosphate. J. Biol. Chem. 273:1998;18040-18046.
172. Tonai T., Shiba K., Taketani Y., Ohmoto Y., Murata K., Muraguchi M., Ohsaki H., Takeda E., Nishisho T. A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats. J. Neurochem. 78:2001;1064-1072.
173. Tsui-Pierchala B.A., Encinas M., Milbrandt J., Johnson E.M. Jr. Lipid rafts in neuronal signaling and function. Trends Neurosci. 25:2002;412-417.
174. Turnley A.M., Bartlett P.F. Cytokines that signal through the leukemia inhibitory factor receptor-beta complex in the nervous system. J. Neurochem. 74:2000;889-899.
175. Tyor W.R., Avgeropoulos N., Ohlandt G., Hogan E.L. Treatment of spinal cord impact injury in the rat with transforming growth factor-beta. J. Neurol. Sci. 200:2002;33-41.
176. Vartanian T., Li Y., Zhao M., Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1:1995;732-743.
177. Vartanian T., Goodearl A., Viehover A., Fischbach G. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J. Cell Biol. 137:1997;211-220.
178. Vinson M., Rausch O., Maycox P.R., Prinjha R.K., Chapman D., Morrow R., Harper A.J., Dingwall C., Walsh F.S., Burbidge S.A., Riddell D.R. Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Mol. Cell. Neurosci. 22:2003;344-352.
179. Vogt M., Bauer M.K., Ferrari D., Schulze-Osthoff K. Oxidative stress and hypoxia/reoxygenation trigger CD95 (APO-1/Fas) ligand expression in microglial cells. FEBS Lett. 429:1998;67-72.
180. Wajant H. The Fas signaling pathway: more than a paradigm. Science. 296:2002;1635-1636.
181. Wallace M.C., Tator C.H., Lewis A.J. Chronic regenerative changes in the spinal cord after cord compression injury in rats. Surg. Neurol. 27:1987;209-219.
182. Wang K.C., Kim J.A., Sivasankaran R., Segal R., He Z. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature. 420:2002;74-78.
183. Wang K.C., Koprivica V., Kim J.A., Sivasankaran R., Guo Y., Neve R.L., He Z. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 417:2002;941-944.
184. Warden P., Bamber N.I., Li H., Esposito A., Ahmad K.A., Hsu C.Y., Xu X.M. Delayed glial cell death following wallerian degeneration in white matter tracts after spinal cord dorsal column cordotomy in adult rats. Exp. Neurol. 168:2001;213-224.
185. Watanabe T., Yamamoto T., Abe Y., Saito N., Kumagai T., Kayama H. Differential activation of microglia after experimental spinal cord injury. J. Neurotrauma. 16:1999;255-265.
186. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
187. Xu J., Fan G., Chen S., Wu Y., Xu X.M., Hsu C.Y. Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats. Brain Res., Mol. Brain Res. 59:1998;135-142.
188. Yamashita T., Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat. Neurosci. 14:2003;14.
189. Yamashita T., Higuchi H., Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157:2002;565-570.
190. Yan P., Li Q., Kim G.M., Xu J., Hsu C.Y., Xu X.M. Cellular localization of tumor necrosis factor-alpha following acute spinal cord injury in adult rats. J. Neurotrauma. 18:2001;563-568.
191. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21:2001;3740-3748.
192. Yoon S.O., Casaccia-Bonnefil P., Carter B., Chao M.V. Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J. Neurosci. 18:1998;3273-3281.
193. Young W. Spinal cord contusion models. Prog. Brain Res. 137:2002;231-255.
194. Yune T.Y., Chang M.J., Kim S.J., Lee Y.B., Shin S.W., Rhim H., Kim Y.C., Shin M.L., Oh Y.J., Han C.T., Markelonis G.J., Oh T.H. Increased production of tumor necrosis factor-alpha induces apoptosis after traumatic spinal cord injury in rats. J. Neurotrauma. 20:2003;207-219.
195. Zheng B., Ho C., Li S., Keirstead H., Steward O., Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron. 38:2003;213-224.
196. Zipfel G.J., Babcock D.J., Lee J.M., Choi D.W. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J. Neurotrauma. 17:2000;857-869.